Henry Schein, Inc. (HSIC): Price and Financial Metrics
Henry Schein, Inc. (HSIC)
Today's Latest Price: $63.24 USD
Updated Jun 3 6:55pm
Add HSIC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
HSIC Stock Summary
- HSIC has a market capitalization of $9,025,037,607 -- more than approximately 84.43% of US stocks.
- Of note is the ratio of Henry Schein Inc's sales and general administrative expense to its total operating expenses; 85.49% of US stocks have a lower such ratio.
- Revenue growth over the past 12 months for Henry Schein Inc comes in at -18.53%, a number that bests just 10.43% of the US stocks we're tracking.
- Stocks that are quantitatively similar to HSIC, based on their financial statements, market capitalization, and price volatility, are AAP, FNF, AOS, LKQ, and MHK.
- HSIC's SEC filings can be seen here. And to visit Henry Schein Inc's official web site, go to www.henryschein.com.
HSIC Stock Price Chart More Charts
HSIC Price/Volume Stats
| Current price | $63.24 | 52-week high | $73.99 |
| Prev. close | $63.22 | 52-week low | $41.85 |
| Day low | $62.87 | Volume | 1,098,000 |
| Day high | $64.20 | Avg. volume | 1,779,242 |
| 50-day MA | $53.86 | Dividend yield | N/A |
| 200-day MA | $62.11 | Market Cap | 9.03B |
Henry Schein, Inc. (HSIC) Company Bio
Henry Schein Inc. is the world's largest provider of health-care products and services to office-based dental, animal health and medical practitioners. The company was founded in 1932 and is based in Melville, New York.
HSIC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $63.24 | $60.91 | 0% |
We started the process of determining a valid price forecast for Henry Schein Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Henry Schein Inc ranked in the 47th percentile in terms of potential gain offered. As for the metrics that stood out in our discounted cash flow analysis of Henry Schein Inc, consider:
- HSIC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 32.44% of tickers in our DCF set.
- Henry Schein Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 21.64. This coverage rate is greater than that of 87.16% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- The weighted average cost of capital for the company is 7. This value is greater than only 19.91% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -2% |
| 1% | -1% |
| 2% | 0% |
| 3% | 1% |
| 4% | 2% |
| 5% | 3% |
ACIU, GILD, HCSG, LH, and ADMT can be thought of as valuation peers to HSIC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...